{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:53:50Z","timestamp":1787072030445,"version":"build-2736575974"},"reference-count":43,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","award":["scholarship project ID: 91826570"],"award-info":[{"award-number":["scholarship project ID: 91826570"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"award":["scholarship project ID: 91826570"],"award-info":[{"award-number":["scholarship project ID: 91826570"]}],"id":[{"id":"https:\/\/ror.org\/039djdh30","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Lipid nanoparticles are widely investigated as oral drug delivery systems, but their intestinal performance remains difficult to predict based only on physicochemical properties. This study aimed to elucidate how the lipid matrix composition influences the intestinal permeation of curcumin from lipid nanoparticles. Methods: Curcumin-loaded nanoemulsions, nanostructured lipid carriers with defined solid-to-liquid lipid ratios, and solid lipid nanoparticles were prepared by high-pressure homogenization. All formulations were characterized with respect to particle size, polydispersity index, and zeta potential before and after simulated intestinal pre-incubation in a simplified SDS-containing intestinal fluid. Intestinal permeation was evaluated ex vivo using porcine gut tissue by analysis of semi-quantitative fluorescence-based permeation readouts (ART) and mean permeation depth (MPD) after 30 and 60 min. Results: All formulations maintained stable physicochemical properties with particle sizes around 200 nm and negative zeta potentials; pre-incubation increased the negativity of the zeta potential but left particle size unchanged. Despite similar attributes, the formulations differed in intestinal curcumin permeation based on time and composition. At 30 min, nanoemulsions and mixed nanostructured lipid carriers achieved the highest performance. By 60 min, lipid carriers with more liquid lipid significantly increased both the fluorescence intensity and the depth of curcumin permeation, while other systems showed little further improvement. Conclusions: The intestinal permeation of drug from lipid nanoparticles is governed by the lipid matrix architecture and its interaction with the hydrated intestinal environment, which together affect drug-release kinetics and the ability to sustain a trans-epithelial concentration gradient over time. Thus, optimizing oral lipid nanoparticles requires time-resolved, biologically relevant models rather than physicochemical characterization alone, consistent with observed similar matrix-driven effects in dermal delivery systems.<\/jats:p>","DOI":"10.3390\/pharmaceutics18081024","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:12:11Z","timestamp":1787069531000},"page":"1024","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of Lipid Matrix Composition on the Intestinal Permeation of Curcumin-Loaded Lipid Nanoparticles"],"prefix":"10.3390","volume":"18","author":[{"given":"Anam Sajjad","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Philipps-Universit\u00e4t Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-4649","authenticated-orcid":false,"given":"Daniela","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Philipps-Universit\u00e4t Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-2340","authenticated-orcid":false,"given":"Cornelia M.","family":"Keck","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Philipps-Universit\u00e4t Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alqahtani, M.S., Kazi, M., Alsenaidy, M.A., and Ahmad, M.Z. (2021). Advances in Oral Drug Delivery. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.618411"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12951-025-03479-8","article-title":"Advanced oral drug delivery systems for gastrointestinal targeted delivery: The design principles and foundations","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sun, D., Wang, J., Li, X., Peng, J., and Wang, S. (2026). Advances and Perspectives in Curcumin Regulation of Systemic Metabolism: A Focus on Multi-Organ Mechanisms. Antioxidants, 15.","DOI":"10.3390\/antiox15010109"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jfda.2015.01.007","article-title":"Application of polymeric nanoparticles and micelles in insulin oral delivery","volume":"23","author":"Alai","year":"2015","journal-title":"J. Food Drug Anal."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jconrel.2016.07.050","article-title":"Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement","volume":"240","author":"Rezhdo","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","article-title":"20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications","volume":"8","author":"Shegokar","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_8","first-page":"4391","article-title":"Nanotechnology-based approaches in anticancer research","volume":"7","author":"Jabir","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-973X.167661","article-title":"Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs","volume":"5","author":"Khan","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","article-title":"Oral lipid-based drug delivery systems\u2014An overview","volume":"3","author":"Kalepu","year":"2013","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014drug release and release mechanism","volume":"45","author":"Schwarz","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"Radtke","year":"2002","journal-title":"Int. J. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111305","DOI":"10.1016\/j.colsurfb.2020.111305","article-title":"Solid lipid nanoparticles for enhanced oral absorption: A review","volume":"196","author":"Salah","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bay\u00f3n-Cordero, L., Alkorta, I., and Arana, L. (2019). Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials, 9.","DOI":"10.3390\/nano9030474"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control. Release"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120109","DOI":"10.1016\/j.ijpharm.2020.120109","article-title":"Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis","volume":"593","author":"Khan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s13346-021-01021-5","article-title":"Are lipid nanoparticles really superior? A holistic proof of concept study","volume":"12","author":"Wiemann","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2021.08.016","article-title":"Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles","volume":"338","author":"Keck","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release","volume":"133","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.apsb.2021.03.025","article-title":"In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives","volume":"11","author":"Huang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mohite, P., Singh, S., Pawar, A., Sangale, A., and Prajapati, B.G. (2023). Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs. Front. Drug Deliv., 3.","DOI":"10.3389\/fddev.2023.1232012"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Umerska, A., Gaucher, C., Oyarzun-Ampuero, F., Fries-Raeth, I., Colin, F., Villamizar-Sarmiento, M.G., Maincent, P., and Sapin-Minet, A. (2018). Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin. Antioxidants, 7.","DOI":"10.3390\/antiox7040046"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Abdelkader, A., Preis, E., and Keck, C.M. (2022). SmartFilm Tablets for Improved Oral Delivery of Poorly Soluble Drugs. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091918"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000514498","article-title":"Dermal Penetration Analysis of Curcumin in an ex vivo Porcine Ear Model Using Epifluorescence Microscopy and Digital Image Processing","volume":"34","author":"Pelikh","year":"2021","journal-title":"Skin Pharmacol. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Keck, C.M., Abdelkader, A., Pelikh, O., Wiemann, S., Kaushik, V., Specht, D., Eckert, R.W., Alnemari, R.M., Dietrich, H., and Br\u00fc\u00dfler, J. (2022). Assessing the Dermal Penetration Efficacy of Chemical Compounds with the Ex-Vivo Porcine Ear Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030678"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hasan, M., Elkhoury, K., Kahn, C.J.F., Arab-Tehrany, E., and Linder, M. (2019). Preparation, Characterization, and Release Kinetics of Chitosan-Coated Nanoliposomes Encapsulating Curcumin in Simulated Environments. Molecules, 24.","DOI":"10.3390\/molecules24102023"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chaiprateep, E.-O., Wiemann, S., Eckert, R.W., Raab, C., Sengupta, S., and Keck, C.M. (2023). Influence of Dose, Particle Size and Concentration on Dermal Penetration Efficacy of Curcumin. Pharmaceutics, 15.","DOI":"10.20944\/preprints202310.0242.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_31","unstructured":"JASP Team (2026, June 05). JASP, Available online: https:\/\/jasp-stats.org."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/1028415X.1999.11747262","article-title":"The Analysis of Variance (ANOVA)","volume":"2","author":"Thompson","year":"1999","journal-title":"Nutr. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cohen, J. (2013). Statistical Power Analysis for the Behavioral Sciences, Routledge. [2nd ed.].","DOI":"10.4324\/9780203771587"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1536867X1501500117","article-title":"Nonparametric Pairwise Multiple Comparisons in Independent Groups using Dunn\u2019s Test","volume":"15","author":"Dinno","year":"2015","journal-title":"Stata J. Promot. Commun. Stat. Stata"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e25131","DOI":"10.1016\/j.heliyon.2024.e25131","article-title":"On the use of post-hoc tests in environmental and biological sciences: A critical review","volume":"10","author":"Agbangba","year":"2024","journal-title":"Heliyon"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, R.F.S., Martins, J.T., Abrunhosa, L., Vicente, A.A., and Pinheiro, A.C. (2021). Nanoemulsions for Enhancement of Curcumin Bioavailability and Their Safety Evaluation: Effect of Emulsifier Type. Nanomaterials, 11.","DOI":"10.3390\/nano11030815"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2019.09.007","article-title":"Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier","volume":"144","author":"Nazir","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Malkawi, A., Alrabadi, N., and Kennedy, R.A. (2021). Dual-Acting Zeta-Potential-Changing Micelles for Optimal Mucus Diffusion and Enhanced Cellular Uptake after Oral Delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13070974"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2014.10.029","article-title":"Oil-enriched, ultra-small nanostructured lipid carriers (usNLC): A novel delivery system based on flip-flop structure","volume":"477","author":"Keck","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/gidisord6010023","article-title":"A Critical Review on In Vitro and Ex Vivo Models of the Intestinal Epithelium of Humans and Monogastric Animals","volume":"6","author":"Costa","year":"2024","journal-title":"Gastrointest. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ghiselli, F., Rossi, B., Piva, A., and Grilli, E. (2021). Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.723387"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejpb.2014.12.008","article-title":"Ultra-small lipid nanoparticles promote the penetration of coenzyme Q10 in skin cells and counteract oxidative stress","volume":"89","author":"Lohan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejpb.2016.10.020","article-title":"Determination of nanostructures and drug distribution in lipid nanoparticles by single molecule microscopy","volume":"110","author":"Boreham","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/1024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:15:23Z","timestamp":1787069723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/1024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmaceutics18081024"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18081024","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}